t
Halma plc announced on 24 June 2026 that its Annual Report and Accounts 2026 and Notice of Meeting have been posted to shareholders and are available on the company's website. Copies of these documents and the Proxy Form have been submitted to the National Storage Mechanism. The Full Year Results, containing DTR 6.3.5R information, were released on 11 June 2026 and are also available on Halma's website.
| Date | 24 Jun 2026 |
| Time | 16:53:51 |
| Category | Results |
| ID | 6375J |
Halma plc
Annual Report and Accounts 2026 and Notice of Annual General Meeting
Halma announces that the Annual Report and Accounts 2026 and the Notice of Meeting have been posted to shareholders (where applicable) and, in accordance with Disclosure Guidance and Transparency Rule 6.3.5(3)R, are available to view on the Company's website at www.halma.com.
Copies of these documents and the Proxy Form have been submitted to the National Storage Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
The Full Year Results, containing information required under Disclosure Guidance and Transparency Rule 6.3.5R were released on 11 June 2026 and are also available on the Company's website.
|
For further information, please contact: |
|
|
|
|
|
Mark Jenkins Company Secretary, Halma plc Tel: +44 (0)1494 721111 |
|
NOTE TO EDITORS
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three market areas where it operates:
|
· Safety |
Protecting people, assets and infrastructure in commercial, industrial and public spaces. Reducing safety risks in hazardous situations, increasing efficiency and helping to create a more sustainable future.
|
|
· Environmental & Analysis |
Monitoring and protecting the environment, and ensuring the quality and availability of life‑critical resources. Creating solutions used in materials analysis and optoelectronic applications.
|
|
· Healthcare
|
Improving the care delivered by healthcare providers, and enhancing the quality of patients' lives, through contributing to the discovery and development of new cures, the diagnosis and treatment of patient conditions, and data analysis. |
Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.
Halma has been named one of Britain's Most Admired Companies for the past seven years.